Erythropoietin Injection

Erythropoietin Injection is used to replace the erythropoietin that is lacking in people who can’t make enough, usually because their kidneys are not working properly. Erythropoietin is used to treat anemia in people with chronic kidney disease (CKD), whether or not they are on dialysis.

Erythropoietin is produced naturally in the body, mostly by the kidneys. It gives bone marrow the signal to produce red blood cells (RBCs), which carry oxygen in the blood. Erythropoietin works by causing increased red blood cell production by the body. If the body does not produce enough erythropoietin, severe anemia (lack of oxygen reaching the different parts of the body) can occur.Erythropoietin is also used to treat people with cancer who develop anemia because of chemotherapy treatment.Erythropoietin is also used to treat anemia before certain surgeries and for people with HIV who are taking the medication zidovudine

There are many generic manufacturers in India who manufacture Erythropoietin Injection including Emcure Pharmaceuticals Ltd etc.

3s corporation is Supplier,Exporter ,Wholesaler  for Erythropoietin Injection in India.

For children with chronic renal failure, the starting dose for anemia is 50 units (IU) per kilogram body weight, given 3 times a week.

For adults with chronic renal failure, the starting dose for anemia is 50 to 100 units per kilogram of body weight, injected three times a week.

For anemia in adults with HIV, the usual starting dose is 100 units per kilogram body weight, injected 3 times a week.

For people with anemia due to chemotherapy, the starting dose is 150 units per kilogram of body weight, injected subcutaneously 3 times a week. As an alternative, Erythropoietin may be injected subcutaneously once weekly as a dose of 40,000 units.

  •   hives
  • difficulty breathing
  • swelling of your face, lips, tongue, or throat.

Patient should contact doctor if he feels weak, lightheaded, or short of breath, or if Patient’s skin looks pale. These may be signs that patient body has stopped responding to this medication.

Erythropoietin can increase  risk of life-threatening heart or circulation problems, including heart attack or stroke. This risk will increase the longer patient use Erythropoietin.